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The development of a successful health care system should be supported by information on the frequency of specific diseases and their contribution to morbidity and mortality in the population. Therefore, measuring mortality, including cause-of-death determination, enhances every level of health care planning, resource allocation and service delivery systems ([@CIT0001], [@CIT0002]). Unfortunately, many countries with the greatest demand for this information have weak health systems that do not generate the requisite information to establish cause-of-death distributions ([@CIT0003], [@CIT0004]) as they also lack functional vital registration systems to capture all the deaths in their populations at specific periods ([@CIT0005]). This is particularly true for sub-Saharan Africa where the majority of deaths occur at home with little or no chance of the cause of death being certified by qualified medical personnel. In this context, verbal autopsy (VA), despite its known limitations, is the most viable option for generating representative cause-of-death information.

The VA approach to determination of the cause of death is described in detail elsewhere ([@CIT0005]). Used predominantly in research settings, the range of methods adopted for cause-of-death assignment includes physician-certification, data-derived algorithms, application of Bayes' theorem, and direct statistical estimation of cause fractions ([@CIT0002]). Physician-certified VA (PCVA) is an established method for assigning cause of death, but it is time consuming. Different approaches more suitable for resource-challenged settings have been developed ([@CIT0006]). These include the InterVA, a computer-based automated VA coding model, and the adoption by WHO of a set of standardised questionnaires that facilitate comparison across different geographical and environmental settings ([@CIT0007]). InterVA has been validated in different settings throughout its evolution ([@CIT0008]--[@CIT0011]).

The Gambia, like many other low-income countries, does not have a functional civil and vital registration system. Health facilities are also unable to provide such information. The only available information on causes of death derives from studies focused on specific target groups (mainly children aged under 5 years) ([@CIT0012]--[@CIT0014]) and from a hospital-based study in Banjul, representing a largely urban area ([@CIT0015]). There are no data on the cause-of-death structure and its evolution over time at the national or sub-national level. However, relevant data have been collected routinely in a population of about 45,000 people in the town of Farafenni and its environs in the North Bank Region of The Gambia as part of the Farafenni Health and Demographic Surveillance System (HDSS). VAs conducted for deaths that occurred between 1998 and 2007 were used to evaluate the cause-of-death patterns and to establish the disease-specific mortality burdens for this part of The Gambia.

Methods {#S0002}
=======

Study area {#S0002-S20001}
----------

The Farafenni HDSS was established in the North Bank Region of The Gambia in 1981 in two geographically contiguous clusters of 42 rural villages to the east and west of the town of Farafenni (population 25,000). In October 2002, the surveillance area was expanded to include Farafenni Town and 23 settlements within a 5-km radius of the town (see [Fig. 1](#F0001){ref-type="fig"}). The majority of the residents are subsistence farmers with very few earning salaries from employment. Detailed socio-demographic characteristics of the population are described elsewhere ([@CIT0013]).

![Location of the urban and contiguous rural areas east and west of Farafenni Town, which collectively constitute the Farafenni Health and Demographic Surveillance area.](GHA-7-25598-g001){#F0001}

Malaria transmission is highly seasonal with most infections occurring between September and November. It was highly endemic in the past but has now declined substantially ([@CIT0016]). The health care system consists of an under-resourced village-based primary health care system that has been operational since 1983 made up of 16 PHC Posts and five Dispensaries, a Health Centre for reproductive and child health services, and a 250-bed referral district hospital in the town of Farafenni, which was commissioned in 1999. Immunisation coverage levels for individual vaccines against childhood diseases are high ([@CIT0017]), and use of ITNs is widespread ([@CIT0018]). For the period 2000--2001, HIV prevalence among pregnant women in The Gambia was 1.0% for HIV-1 and 0.8% for HIV-2, and the corresponding levels for Farafenni were 0.4 and 0.3%, respectively ([@CIT0019]). From a similar sentinel surveillance in 2008, the national prevalence levels were 1.6% for HIV1 and 0.4% for HIV2 ([@CIT0020]). The majority of deaths occur at home and burials are held almost immediately or within a few hours after death, in line with religious beliefs. This constitutes a barrier to having deaths medically certified or being captured by vital registration.

Data and statistical analysis {#S0002-S20002}
-----------------------------

The surveillance procedures of the Farafenni HDSS are described in detail elsewhere ([@CIT0013], [@CIT0021]). The administration of VAs was introduced in 1998 for a sample of deaths and for specific study purposes. Routine administration of VA for every death in the area using the 2002 standard WHO VA questionnaires for neonates, children and adults commenced in 2005. VAs were administered retrospectively for deaths that occurred before 2005. VA interviews are conducted at least 40 days after death by trained fieldworkers, but the time lapse between death and interview has spanned up to 3 years in some cases. The main carers of the deceased persons prior to their deaths are targeted for the interviews, or if they are not available, other close relatives who were present during the period of illness and death. Interviews were conducted in one of the three main local languages spoken in the area.

The data collected using the three different age-specific questionnaires have been systematically transformed into the InterVA-4 input format and merged together. Responses for questions in the InterVA-4 format that could not be derived from the original data were coded as missing. InterVA-4 was applied with malaria prevalence set as 'high' and HIV prevalence as 'low', reflecting the situation in the study area for the period covered by this study and as recommended for West African regions. The data forms part of the INDEPTH Network pooled dataset for cause-of-death analyses covering Farafenni HDSS and 21 other INDEPTH HDSS sites ([@CIT0022]).

The assigned causes of death were classified into six broad groups: infectious and parasitic diseases, cancers, other non-communicable diseases, neonatal, maternal, and external causes. In the analysis presented here, cause-specific mortality fractions (CSMFs) are derived from the three most likely causes of death and the residual indeterminate fraction assigned by InterVA-4 using disease codes in version 10 of the International Statistical Classification of Diseases and Related Health Problems, ICD-10. The output was merged with the detailed individual level data and analysed using STATA version 12 (Stata Corporation, College Station, TX, USA). Cause-specific mortality rates were calculated as the number of cause-specific deaths per 1,000 person-years of follow-up. They were derived using survival analysis techniques and Poisson regression, and individual deaths were associated with the most likely cause of death. Statistical significance at the 95% confidence level was determined using likelihood ratio tests. Since annual cause-specific mortality rates would not be meaningful due to small numbers of cause-specific deaths, the study period was divided up into three short periods with roughly similar numbers of deaths for the assessment of cause-specific mortality trends. These were defined *a priori* as 1998--2001, 2002--2004, and 2005--2007.

The Joint MRC/Gambia Government Ethics committee approved the establishment of the Farafenni HDSS and all instruments used to collect household and individual level information, including the VA questionnaires. Verbal consent was obtained for the administration of all VA questionnaires.

Results {#S0003}
=======

The mid-year population of the Farafenni HDSS in 1998 was 15,960 with a mean age of 23.0 years; and 44,644 in 2007 with a mean age 22.4 years. The age structure remained the same with 18% of the population aged less than 5 years in both periods; whilst the proportion aged 15 years and over was 53% in 1998 and 55% in 2007. Between 1 January 1998 and 31 December 2007, 3,203 deaths were recorded and VAs were administered for 2,275 (71%) of them. Annual VA coverage improved progressively from about 50% in the first 3 years of the study period and peaked at 87% in 2003. Coverage was generally high among adults aged 15 years or more throughout the study period. There was no difference in VA coverage by gender or area of residence.

Overall mortality declined by a third in the rural part of the demographic surveillance area over the 10-year period, a decline from 15 per 1,000 person-years in 1998--2001 to 10 per 1,000 person-years in 2005--2007 and by 12.5% in the urban part between 2002--2004 and 2005--2007, a decline from 8 to 7 per 1,000 person-years ([Table 1](#T0001){ref-type="table"}). Mortality dropped by 55% among infants (from 78 to 35 per 1,000 person-years) and by 74% among children 1--4 years old (from 27 to 7 per 1,000 person-years). Overall mortality rates did not vary appreciably between ethnic groups in any of the three periods; and females had a lower mortality rate than males throughout.

###### 

Number of deaths, proportion of deaths with verbal autopsy and death rates by period and population

                                            All     1998--2001   2002--2004   2005--2007                                                              
  ----------------------------------------- ------- ------------ ------------ ------------ ---------- ---- ------- ---------- ---- ------- ---------- ----
  Age group                                                                                                                                           
   \<1 year                                 536     224 (42)     47           201          20 (10)    78   162     122 (75)   42   173     82 (47)    35
   1--4 years                               559     295 (53)     13           246          24 (10)    27   188     163 (87)   12   125     108 (86)   7
   5--14 years                              204     137 (67)     2            81           38 (47)    4    67      59 (88)    2    56      40 (71)    2
   15--59 years                             891     715 (80)     6            187          180 (96)   6    368     303 (82)   6    336     232 (69)   5
   60+ years                                1,013   904 (89)     58           287          280 (98)   63   359     331 (92)   59   367     293 (80)   54
  Sex                                                                                                                                                 
   Male                                     1,727   1,217 (70)   12           531          287 (54)   17   609     522 (86)   11   587     408 (70)   9
   Female                                   1,476   1,058 (72)   9            471          255 (54)   14   535     456 (85)   9    470     347 (74)   7
  Ethnic group                                                                                                                                        
   Wollof                                   1,192   825 (69)     10           349          172 (49)   15   418     355 (85)   9    425     298 (70)   8
   Mandinka                                 1,262   950 (75)     11           453          272 (60)   16   428     386 (90)   11   381     292 (77)   9
   Fula                                     629     416 (66)     9            194          95 (49)    14   239     195 (82)   10   196     126 (64)   7
   Other                                    120     84 (70)      7            6            3 (50)     9    59      42 (71)    8    55      39 (71)    6
  Area of residence                                                                                                                                   
   Rural                                    2,145   1,491 (70)   13           1,002        542 (54)   15   635     572 (90)   12   508     377 (74)   10
   Urban[a](#TF0001){ref-type="table-fn"}   1,058   784 (74)     7                                         509     406 (80)   8    549     378 (69)   7
  All                                       3,203   2,275 (71)   10           1,002        542 (54)   15   1,144   978 (85)   10   1,057   755 (71)   8

Surveillance in this area started in October 2002.

CSMFs generated by InterVA-4 are presented in [Table 2](#T0002){ref-type="table"} by age group, sex, area of residence and ethnicity. Almost half (49.9%) of deaths over the 10-year period were attributed to communicable diseases. These were dominated by acute respiratory infections (ARI) (13.7%), malaria (12.9%) and pulmonary tuberculosis (10.2%). A similar pattern of cause-specific mortality proportions was maintained in all three periods. However, the proportion of HIV-related deaths showed an increasing trend over the three periods.

###### 

Cause-specific mortality fractions (CSMFs) derived using recommended InterVA-4 settings by age group, period, sex, residence and ethnicity

  Classification and causes of death   Total   \<1 year   1--4 years   5--14 years   15--59 years   60+ years   1998--2001   2002--2004   2005--2007   Male    Female   Rural   Urban   Wollof   Mandinka   Fula   Other
  ------------------------------------ ------- ---------- ------------ ------------- -------------- ----------- ------------ ------------ ------------ ------- -------- ------- ------- -------- ---------- ------ -------
  Number of deaths                     2,275   224        295          137           715            904         542          978          755          1,217   1,058    1,491   784     825      950        416    84
  Infectious diseases                                                                                                                                                                                              
   Malaria                             12.9    15.8       38.3         28.3          7.5            5.9         10.7         14           12.9         12.3    13.5     13      12.6    15.4     10.3       13.5   13.9
   ARI, including pneumonia            13.7    28.1       15.2         11.7          9.9            12.9        13.5         13.8         13.6         15      12.2     14      13      14.5     13.1       13.8   11.3
   Pulmonary tuberculosis              10.2               0.4          1             14             14.3        10.2         9.7          10.8         12.6    7.4      9.6     11.3    7.4      12.5       8.8    17.5
   HIV/AIDS-related                    5.8     5.9        15           8.7           6.6            1.9         3.3          6.2          7.2          4.3     7.6      4.8     7.8     6.5      4.5        7.3    8
   Diarrhoeal diseases                 3.9     10.2       8.3          0.9           3.7            1.7         4.2          3.8          3.9          4       3.8      4.3     3.3     3.4      4.2        4.7    2.1
   Meningitis and encephalitis         2.2     1.5        1.3          6.5           2.7            1.5         3            1.8          2            2.1     2.2      2.1     2.2     2.5      1.4        2.8    4.2
   Other infectious diseases           1.2     0.1        0.1          2.8           1.6            1.2         1.1          1.4          1            1.7     0.6      1.2     1.2     0.9      1.2        1.6    0.7
  Cancers                                                                                                                                                                                                          
   Digestive neoplasms                 3.1                                           5.3            3.5         3            3            3.3          3.6     2.5      2.8     3.6     3.1      3.1        3.4    1.1
   Respiratory neoplasms               1.6                                           1.6            2.7         2.3          1.5          1.3          2.4     0.7      1.8     1.3     0.8      2.2        1.5    3.3
   Reproductive neoplasms              1.3                                           1.6            2.1         1.8          1.3          1            1       1.7      1.4     1.1     1.3      1.4        1.2    0.9
   Other neoplasms                     0.9                                           3.2            3.8         3            2.4          2.3          2.7     2.3      2.5     2.5     2.4      2.9        1.9    2.3
  Other NCDs                                                                                                                                                                                                       
   Stroke                              6.4                                           4.2            12.8        5.6          6.8          6.5          5.4     7.6      5.9     7.5     5.9      6.4        7.6    6.3
   Acute abdomen                       4.8     0.4        0.2          9.7           5.6            6           6.5          3.9          4.8          4.5     5.1      5       4.5     4.2      6.2        3.2    3.4
   Severe malnutrition                 1.6     3.4        6            1.5           0.2            0.8         0.8          1.7          2.1          1.6     1.5      1.5     1.9     2.1      1.4        1.3    0.9
   Acute cardiac diseases              0.9                                           0.8            1.5         1            0.6          1            0.8     0.9      0.9     0.8     1.3      0.7        0.5    
   Other cardiac diseases              1.3     0.5        0.8          2.2           1.1            1.7         1            1.5          1.4          1.3     1.3      1       2       1.6      1.2        1.1    1
   Other unspecified NCDs              2.5     0.1        0.8          1.2           3              3.5         2.5          2.2          3            2.2     2.9      2.6     2.3     2.4      3.1        2      
   Liver cirrhosis                     2.5                             1.8           0.8            1.3         0.5          0.9          1.1          1.1     0.7      1.1     0.6     1        0.5        1.6    1.2
  Neonatal                             2       20.6                                                             1.4          3.2          0.9          1.5     2.6      2.9     0.4     2.1      2.1        1.6    2.4
  External                             2.5     0.7        1.2          5.9           3.8            1.7         2.9          2.1          2.6          2.7     2.2      2.4     2.5     2.2      2.9        2.2    1.8
  Maternal                             2.1                                           6.8                        2.6          2.3          1.5                  4.6      2       2.4     2.7      1.5        2.4    2.9
  Indeterminate                        16.6    12.8       12.4         17.8          16.2           19.1        19.1         15.9         15.8         17.1    16       17.3    15.3    16.5     17.2       16     14.7
  Total                                100     100        100          100           100            100         100          100          100          100     100      100     100     100      100        100    100

Malaria, ARI and diarrhoeal diseases accounted for more than half (58.5%) of deaths among children aged under 5 years ([Fig. 2](#F0002){ref-type="fig"}); 11% of deaths were attributed to HIV-related causes in this age group. More than a third (38%) of deaths among those aged 15--59 years were due to four communicable diseases: pulmonary tuberculosis (14%), ARI (including pneumonia) (9.9%), malaria (7.5%) and HIV/AIDS (6.5%). Overall, 46 and 37.8% of adult deaths were attributed to communicable and non-communicable diseases respectively.

![Comparison of the distribution of causes of death among children under 5 years of age by InterVA-4 for Farafenni HDSS, 1998--2007 and CHERG estimates for The Gambia, 2008 ([@CIT0027]).](GHA-7-25598-g002){#F0002}

[Table 3](#T0003){ref-type="table"} shows the top five cause-specific mortality rates for each age group and period. Overall, ARI, malaria, diarrhoeal diseases, neonatal sepsis, HIV/AIDS-related illnesses and severe malnutrition had the highest cause-specific mortality rates among children under 5 years of age. ARI mortality was consistently high among infants throughout the study period with an average rate of 5.59 per 1,000 person-years (95% CI: 4.38--7.15), followed by malaria with a rate of 4.11 per 1,000 person-years (95% CI: 3.09--5.47). The reverse pattern was observed among children aged 1--4 years who had a malaria mortality rate of 3.06 per 1,000 person-years (95% CI: 2.58--3.63) and an ARI mortality rate of 1.05 per 1,000 person-years (95% CI: 0.79--1.41). HIV-related mortality had the second highest rate in this age group (1.17 per 1,000 person-years \[95% CI: 0.89--1.54\]). Disease-specific mortality rates among children aged under 5 years increased overall between 1998--2001 and 2002--2004 due to increased VA coverage, but only significantly for malaria in infants (*p=*0.001) and children 1--4 years (*p\<*0.0001). Although at comparatively lower levels, malaria, ARI, acute abdomen and HIV/AIDS constituted the greatest mortality burden among older children aged 5--14 years.

###### 

Top five causes of death by age group and period

                 1998--2007                                         1998--2001   2002--2004          2005--2007                                                                                                                                                                                    
  -------------- -------------------------------------------------- ------------ ------------------- -------------------------------------------------- ---- --------------------- -------------------------------------------------- ---- -------------------- ----------------------------- ---- -------------------
  \<1 year                                                                                                                                                                                                                                                                                         
  1              ARI, including pneumonia                           64           5.59 (4.38--7.15)   Neonatal sepsis                                    4    1.54 (0.58--4.11)     ARI, including pneumonia                           36   9.34 (6.74--13.00)   ARI, including pneumonia      25   5.01 (3.38--7.41)
  2              Malaria                                            47           4.11 (3.09--5.47)   Malaria                                            4    1.54 (0.58--4.11)     Malaria                                            21   5.45 (3.55--8.36)    Malaria                       22   4.41 (2.90--6.69)
  3              Neonatal sepsis                                    31           2.71 (1.91--3.85)   ARI, including pneumonia                           3    1.16 (0.37--3.59)     Neonatal Sepsis                                    21   5.45 (3.55--8.36)    Diarrhoeal diseases           10   2.00 (1.08--3.72)
  4              Diarrhoeal diseases                                24           2.10 (1.41--3.13)   Neonatal pneumonia                                 2    0.77 (0.19--3.08)     Diarrhoeal diseases                                12   3.11 (1.77--5.48)    Neonatal sepsis               6    1.20 (0.54--2.68)
  5              HIV/AIDS-related                                   14           1.22 (0.72--2.07)   Other neonatal causes                              2    0.77 (0.19--3.08)     Neonatal pneumonia                                 9    2.33 (1.21--4.49)    HIV/AIDS-related              6    1.20 (0.54--2.68)
                 Indeterminate                                      11                               Indeterminate                                      0                          Indeterminate                                      7                         Indeterminate                 4    
  1--4 years                                                                                                                                                                                                                                                                                       
  1              Malaria                                            131          3.06 (2.58--3.63)   Malaria                                            16   1.78 (1.09--2.91)     Malaria                                            78   4.92 (3.94--6.14)    Malaria                       37   2.06 (1.49--2.84)
  2              HIV/AIDS-related                                   50           1.17 (0.89--1.54)   Diarrhoeal diseases                                2    0.22 (0.06--0.89)     HIV/AIDS-related                                   27   1.70 (1.17--2.48)    HIV/AIDS-related              23   1.28 (0.85--1.93)
  3              ARI, including pneumonia                           45           1.05 (0.79--1.41)   ARI, including pneumonia                           1    0.11 (0.02--0.79)     ARI, including pneumonia                           25   1.58 (1.06--2.33)    ARI, including pneumonia      19   1.06 (0.67--1.66)
  4              Diarrhoeal diseases                                26           0.61 (0.41--0.89)   Severe malnutrition                                1    0.11 (0.02--0.79)     Diarrhoeal diseases                                13   0.82 (0.48--1.41)    Diarrhoeal diseases           11   0.61 (0.34--1.11)
  5              Severe malnutrition                                18           0.42 (0.26--0.67)   Meningitis and encephalitis                        1    0.11 (0.02--0.79)     Severe malnutrition                                7    0.44 (0.21--0.93)    Severe malnutrition           10   0.56 (0.30--1.03)
                 Indeterminate                                      9                                Indeterminate                                      2                          Indeterminate                                      4                         Indeterminate                 3    
  5--14 years                                                                                                                                                                                                                                                                                      
  1              Malaria                                            47           0.53 (0.40--0.70)   Malaria                                            11   0.58 (0.32--1.05)     Malaria                                            25   0.76 (0.51--1.12)    Malaria                       11   0.30 (0.17--0.54)
  2              ARI, including pneumonia                           16           0.18 (0.11--0.29)   Acute abdomen                                      6    0.32 (0.14--0.71)     HIV/AIDS-related                                   6    0.18 (0.08--0.41)    ARI, including pneumonia      6    0.16 (0.07--0.36)
  3              Acute abdomen                                      15           0.17 (0.10--0.28)   ARI, including pneumonia                           6    0.32 (0.14--0.71)     Acute abdomen                                      6    0.18 (0.08--0.41)    HIV/AIDS-related              6    0.16 (0.07--0.36)
  4              HIV/AIDS-related                                   14           0.16 (0.09--0.27)   External causes                                    3    0.16 (0.05--0.49)     ARI, including pneumonia                           4    0.12 (0.05--0.32)    Acute abdomen                 3    0.08 (0.03--0.25)
  5              External causes                                    9            0.10 (0.05--0.19)   Meningitis and encephalitis                        3    0.16 (0.05--0.49)     External causes                                    3    0.09 (0.03--0.28)    Meningitis and encephalitis   3    0.08 (0.03--0.25)
                 Indeterminate                                      8                                Indeterminate                                      3                          Indeterminate                                      4                         Indeterminate                 1    
  15--59 years                                                                                                                                                                                                                                                                                     
  1              Pulmonary tuberculosis                             107          0.68 (0.57--0.83)   ARI, including pneumonia                           23   0.76 (0.50--1.14)     Pulmonary tuberculosis                             44   0.75 (0.56--1.01)    Pulmonary tuberculosis        44   0.65 (0.49--0.88)
  2              Other infectious diseases                          107          0.68 (0.57--0.83)   Pulmonary tuberculosis                             19   0.62 (0.40--0.98)     Other infectious diseases                          44   0.75 (0.56--1.01)    Other infectious diseases     44   0.65 (0.49--0.88)
  3              ARI, including pneumonia                           78           0.50 (0.40--0.62)   Other infectious diseases                          19   0.62 (0.40--0.98)     ARI, including pneumonia                           37   0.63 (0.46--0.87)    Malaria                       27   0.40 (0.27--0.58)
  4              Malaria                                            61           0.39 (0.30--0.50)   Maternal causes[a](#TF0002){ref-type="table-fn"}   18   0.59 (0.37--0.94)     Maternal causes[a](#TF0002){ref-type="table-fn"}   25   0.43 (0.29--0.63)    HIV/AIDS-related              19   0.28 (0.18--0.44)
  5              Maternal causes[a](#TF0002){ref-type="table-fn"}   56           0.36 (0.28--0.47)   Acute abdomen                                      15   0.49 (0.30--0.82)     HIV/AIDS-related                                   24   0.41 (0.28--0.61)    ARI, including pneumonia      18   0.27 (0.17--0.42)
                 Indeterminate                                      47                               Indeterminate                                      9                          Indeterminate                                      21                        Indeterminate                 17   
  60+ years                                                                                                                                                                                                                                                                                        
  1              Pulmonary tuberculosis                             137          7.84 (6.63--9.27)   ARI, including pneumonia                           47   10.00 (7.79--14.00)   Stroke                                             59   9.62 (7.45--12.00)   Stroke                        43   6.32 (4.69--8.52)
  2              Other infectious diseases                          137          7.84 (6.63--9.27)   Pulmonary tuberculosis                             43   9.49 (7.04--13.00)    Other infectious diseases                          54   8.80 (6.74--11.00)   ARI, including pneumonia      42   6.17 (4.56--8.35)
  3              Stroke                                             134          7.67 (6.48--9.09)   Other infectious diseases                          43   9.49 (7.04--13.00)    Pulmonary tuberculosis                             54   8.80 (6.74--11.00)   Pulmonary tuberculosis        40   5.88 (4.31--8.02)
  4              ARI, including pneumonia                           130          7.44 (6.27--8.84)   Stroke                                             32   7.06 (4.99--9.99)     ARI, including pneumonia                           41   6.68 (4.92--9.08)    Other infectious diseases     40   5.88 (4.31--8.02)
  5              Malaria                                            63           3.61 (2.82--4.62)   Malaria                                            24   5.30 (3.55--7.90)     Acute abdomen                                      20   3.26 (2.10--5.05)    Acute abdomen                 24   3.53 (2.36--5.26)
                 Indeterminate                                      82                               Indeterminate                                      28                         Indeterminate                                      32                        Indeterminate                 22   

Rate based on person-time contributed by women aged 15--49 years who constitute the population at risk of maternal causes of death.

Pulmonary tuberculosis, ARI, malaria and other infectious diseases (i.e. communicable diseases other than those listed in [Table 2](#T0002){ref-type="table"}) were the main causes of death among adults aged 15--59 years. Maternity-related causes also had a relatively high mortality burden among women of reproductive age (15--49 years) (mortality rate of 0.36 per 1,000 person-years \[95% CI: 0.28--0.47\]). Overall, pulmonary tuberculosis and other infectious diseases were the main causes of death of adults in the Farafenni area during the 10-year period, each with a disease-specific mortality rate of 0.68 per 1,000 person-years (95% CI: 0.57--0.83). There was no significant change in their respective mortality rates in the latter two periods compared to the first (*p=*0.567 for 2002--2004 and 0.703 for 2005--2007 for TB; and *p=*0.276 and 0.885 for other infectious diseases for the same periods).

Pulmonary tuberculosis and other infectious diseases, stroke, ARI and malaria were the main causes of death among the elderly population aged 60 years and over. Mortality from stroke emerged in the last 6 years of the study period as the most important cause of death in this age group -- 9.62 per 1,000 person-years in 2002--2004 (95% CI: 7.45--12.00) and 6.32 per 1,000 person-years in 2005--2008 (95% CI: 4.69--8.52).

The mortality burdens of both communicable and non-communicable diseases are summarised in [Table 4](#T0004){ref-type="table"} by period, age group, sex, ethnicity and area of residence. Mortality rates for both categories of disease dropped significantly in 2005--2007 compared with levels in 1998--2001. For all categories of disease, mortality burdens were greater in the rural than in the urban area. Males had a 42% (95% CI: 27--59%) and a 26% (95% CI: 9--47%) higher risk of dying from communicable and non-communicable diseases respectively compared to females. Mandinkas were more likely to die from a non-communicable disease than any other ethnic group (RR 1.45, 95% CI: 1.22--1.71). Cancer-related mortality was significantly higher among men than women (RR 1.66, 95% CI: 1.29--2.15) and among rural rather than urban residents (RR 1.73, 95% CI: 1.33--2.26). Only cancers arising from the reproductive system were more prevalent among females than males.

###### 

Comparison of incidence of communicable and non-communicable diseases in the Farafenni demographic surveillance area by period and socio-demographic characteristics

                                                     Non-communicable diseases                                                                     
  ------------------- ------------------- ---------- --------------------------- ---------- --------------------- ---------- --------------------- ----------
  Period                                                                                                                                           
   1998--2001         1                              1                                      1                                1                     
   2002--2004         1.09 (0.94--1.25)   0.265      0.91 (0.75--1.10)           0.317      0.85 (0.62--1.16)     0.310      0.94 (0.74--1.19)     0.625
   2005--2007         0.75 (0.64--0.87)   \<0.0001   0.67 (0.55--0.81)           \<0.0001   0.59 (0.43--0.82)     0.002      0.71 (0.55--0.90)     0.006
  Age group                                                                                                                                        
    \< 1 year         1                              1                                                                       1                     
   1--4 years         0.45 (0.37--0.55)   \<0.0001   0.64 (0.31--1.34)           0.238                                       0.64 (0.31--1.34)     0.238
   5--14 years        0.08 (0.06--0.10)   \<0.0001   0.34 (0.16--0.69)           0.003                                       0.30 (0.14--0.62)     0.001
   15--60 years       0.17 (0.14--0.21)   \<0.0001   1.64 (0.87--3.09)           0.126      1                                0.90 (0.47--1.72)     0.750
   60+ years          1.68 (1.40--2.03)   \<0.0001   26.85 (14.34--50.28)        \<0.0001   12.31 (9.53--15.91)   \<0.0001   17.75 (9.44--33.36)   \<0.0001
  Sex                                                                                                                                              
   Female             1                              1                                      1                                1                     
   Male               1.42 (1.27--1.59)   \<0.0001   1.26 (1.09--1.47)           0.002      1.66 (1.29--2.15)     \<0.0001   1.09 (0.91--1.31)     0.359
  Ethnic group                                                                                                                                     
   Wollof             1                              1                                      1                                1                     
   Mandinka           1.18 (1.04--1.33)   0.012      1.45 (1.22--1.71)           \<0.0001   1.53 (1.15--2.05)     0.004      1.40 (1.14--1.72)     0.001
   Fula               0.96 (0.82--1.12)   0.615      0.87 (0.70--1.09)           0.235      1.07 (0.74--1.53)     0.728      0.78 (0.59--1.03)     0.085
   Other              0.84 (0.64--1.11)   0.232      0.56 (0.35--0.89)           0.015      0.82 (0.41--1.63)     0.562      0.44 (0.23--0.83)     0.011
  Area of residence                                                                                                                                
   Urban              1                              1                                      1                                1                     
   Rural              1.59 (1.42--1.79)   \<0.0001   1.56 (1.33--1.82)           \<0.0001   1.73 (1.33--2.26)     \<0.0001   1.47 (1.22--1.78)     \<0.0001

Discussion {#S0004}
==========

There has been an appreciable decline in all-cause mortality in the Farafenni HDSS area over the 10-year period considered in this study. However, the pace of decline varied markedly between different age groups. Reduction in childhood mortality, especially among children aged between 1 and 4 years, accounted for much of the overall decline, similar to other countries in sub-Saharan Africa ([@CIT0023], [@CIT0024]). Improvements in the death rates for adults and the elderly were very modest.

With respect to causes of death, the results presented here give the first indication of the cause-specific pattern of mortality for all age groups over a period of time for any geographically defined population in The Gambia. Previous *ad hoc* investigations in the Farafenni HDSS area and other parts of the country used the physician coding method of VAs and focused on populations of interest such as children ([@CIT0012], [@CIT0013], [@CIT0025]), women of reproductive age ([@CIT0026]), or hospital patients ([@CIT0015]). The outcomes of this study are therefore relevant from two perspectives. First, it provides an opportunity to evaluate the cause-of-death structure produced by the InterVA-4 model against the established disease epidemiology of the region and secondly it helps in defining the public health priorities of the area.

Using the recommended settings for malaria and HIV prevalence levels in West Africa, InterVA-4 has produced results that suggest three preventable and treatable diseases accounted for more than half (58%) of all deaths among children aged under 5 years between 1998 and 2007. These were malaria (28%), ARI (21%) and diarrhoeal diseases (9%) ([Fig. 2](#F0002){ref-type="fig"}). These proportions compare reasonably well with the distribution of under-5 deaths in 2008 estimated for The Gambia by the Child Health Epidemiology Reference Group (CHERG), with 53% of under-5 deaths being attributed to malaria, pneumonia and diarrhoeal diseases ([@CIT0027]). These three diseases also dominate the overall cause-of-death structure compiled for children aged under 5 years in sub-Saharan Africa ([@CIT0027], [@CIT0028]). A similar study in Niakhar in central Senegal about 150 km north of the Farafenni HDSS, showed the same pattern of mortality burden among children under 5 years old for these three specific diseases ([@CIT0029]), although malaria cases were included in a broader classification of fevers of unknown origin.

The InterVA-4 results suggest that only about one-tenth (9%) of under-5 deaths were due to neonatal causes, substantially lower than the CHERG estimate of 27% for The Gambia ([Fig. 2](#F0002){ref-type="fig"}). This is likely to be due to the relatively low VA coverage for infants during the study period; only a quarter (51/199) of neonatal deaths had a VA administered. Assuming that all neonatal deaths were due to neonatal causes, this will increase the proportion of under-5 deaths due to neonatal causes to 30%, which is similar to the CHERG estimate.

In view of the relatively low HIV prevalence in Farafenni, InterVA appears to have overestimated the proportion of under-5 deaths from HIV/AIDS, ranking it as the second highest killer among children aged 1--4 years ([Table 3](#T0003){ref-type="table"}). Malnutrition is prevalent in rural Gambia and constitutes a major public health concern. About a quarter of children aged less than 5 years in the North Bank Region of The Gambia are underweight ([@CIT0018]). It is therefore possible that the InterVA-4 model misinterpreted symptoms of malnourishment in children and returned the cause of their deaths as HIV-related, thus overestimating deaths resulting from HIV/AIDS. A similar conclusion was reached in another study in Kenya that compared the outcomes of an earlier version of InterVA and physician coding of the same VAs ([@CIT0011]).

The plausibility of the cause-specific mortality proportions for adults aged 15--59 years was assessed by re-grouping all causes by sex into the categories indicated in [Fig. 3](#F0003){ref-type="fig"} and comparing the resulting patterns of cause and sex-specific mortality rates with those derived for the African region as a whole in 2008 ([@CIT0028]). Apart from differences in the magnitudes of the burdens of HIV/AIDS and external (including injury) mortality, the InterVA-derived cause and sex-specific patterns of mortality among adults in the Farafenni HDSS area are remarkably similar to those of the African region. Common features between the two sets of mortality patterns include higher mortality rates among males for external, communicable and non-communicable disease-related causes of death and a higher HIV/AIDS mortality rate among females than among males. Communicable diseases, especially pulmonary tuberculosis, constitute the greatest mortality burden among adults aged 15--59 years in the Farafenni HDSS area.

![Cause and sex-specific mortality rates among Farafenni adults aged 15--59 years, 1998--2007.](GHA-7-25598-g003){#F0003}

As expected, there were more deaths among the elderly population aged 60 years and over, the group who had the highest VA coverage (89%). However, in the absence of an established cause-of-death structure for the elderly in an epidemiological setting such as that of the Farafenni HDSS, the plausibility of the disease-specific mortality burdens in this age group cannot be assessed with certainty. Judging from the reasonable cause-of-death distributions obtained for children and adults, and the fact that the InterVA-4 model has not returned any unexpected or unreasonable cause or causes of death in the elderly, the cause-of-death structure obtained can be accepted as a reasonable reflection of the pattern of mortality among the elderly in the area. The results show that stroke has emerged as the leading cause of death among this population in the latter part of the period considered. The rise in cardiovascular risk factors in this population to levels prevalent in the main urban centre of The Gambia was established between 1996 and 1997 ([@CIT0030]). Hence, the level of stroke mortality produced by the model is plausible. Decreases in cause-specific mortality rates for this age group were not statistically significant and imply a stable cause-of-death pattern over the study period.

Despite using VA data covering less than three-quarters of all deaths in the period, especially among children aged under 5 years, and transforming these data from their original structure to meet InterVA-4 requirements, the model has proven useful in providing a population-based cause-of-death structure and disease-specific mortality rates for a sub-national population of The Gambia. The derived cause-specific mortality rates should be interpreted as the minimal possible rates because verbal autopsies were not administered for 29% of the deaths considered in the study, especially among children aged less than 5 years. In its Health Policy document for the period 2012--2020, The Gambia government identified the main causes of death in the country, albeit without strong supporting evidence, as malaria, pneumonia, anaemia, diarrhoeal diseases, road traffic accidents, pregnancy complications and cardiovascular diseases ([@CIT0020]). Concern was also expressed over the increasing incidences of tuberculosis and HIV/AIDS. The results of this study reflect the same pattern of disease-specific mortality burden in the Farafenni HDSS area, and confirm the double burden of communicable and non-communicable diseases, which constitute a huge strain on a relatively weak local health care delivery system.

The InterVA-4 model should be subjected to further methodological tests and fine tuning to enhance its performance in an epidemiologically dynamic setting like that of the Farafenni HDSS area. Whilst an earlier study confirmed that the model is capable of detecting a significant epidemic of HIV-related mortality in South Africa ([@CIT0031]), and that the use of VA tracked effectively an epidemiological transition in rural India ([@CIT0032]), it has not been sufficiently validated in settings with changing malaria epidemiology and lower HIV prevalence than the regional level prescribed by the model. With the recent decline in malaria incidence in The Gambia ([@CIT0016], [@CIT0033]), a comparison of the results obtained from this study with those generated by setting the HIV and malaria prevalence levels that reflect the current epidemiological situation will show the extent to which death from communicable diseases will be redistributed. Non-communicable disease-related deaths will not be affected. The outcome of such a comparison will identify and document potential methodological limitations of the model in an environment like the Farafenni HDSS and facilitate future enhancement of the model.
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